$1.19
-0.06-4.80%
At Close: -
$1.27
0.086.72%
After Hours: Aug 20, 7:01 AM EDT
15 minutes delayed
Comments
Loading...
Barinthus Biotherapeutics (NASDAQ:BRNS) Stock, Earnings Estimates, EPS, And Revenue
Barinthus Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS
$-0.430
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Barinthus Biotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Barinthus Biotherapeutics (BRNS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.43 | $-0.41 | -4.88 % |
| Mar 2024 | 2024-05-13 | $-0.40 | $-0.54 | 25.9 % |
| Dec 2023 | 2024-03-20 | $-0.45 | $-0.50 | 10.0 % |
| Sep 2023 | 2023-11-09 | $-0.37 | $-0.53 | 30.2 % |
Barinthus Biotherapeutics (BRNS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $0 | $130.00K | -100.0 % |
| Dec 2023 | 2024-03-20 | $0 | $130.00K | -100.0 % |
| Jun 2023 | 2023-08-10 | $334.00K | $600.00K | -44.3 % |
| Mar 2023 | 2023-05-12 | $468.00K | $1.50M | -68.8 % |
FAQ
When is Barinthus Biotherapeutics (NASDAQ:BRNS) reporting earnings?
Barinthus Biotherapeutics (BRNS) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for Barinthus Biotherapeutics (NASDAQ:BRNS)?
The Actual EPS was $-0.43, which missed the estimate of $-0.41.
What were Barinthus Biotherapeutics’s (NASDAQ:BRNS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.